Follicular Lymphoma
Rituximab Maintenance Improved Long-Term Survival in Elderly With Follicular Lymphoma
September 11, 2018A retrospective analysis of outcomes demonstrated the influence of rituximab maintenance after R-CHOP or R-CVP for follicular lymphoma in elderly patients.
Insurance Status Influences Overall Survival in Follicular Lymphoma
September 11, 2018Outcomes data demonstrated the impact of socioeconomic status and insurance coverage on outcomes for patients with follicular lymphoma by age (younger than 65 and 65 and older).
Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
July 10, 2018Although involved-field radiotherapy (IFRT) has a high level of disease control in patients with follicular lymphoma, relapse frequently occurs; therefore, researchers sought to determine if adding chemotherapy would improve progression-free survival.
Dual Inhibitor for Treating CLL/SLL, Follicular Lymphoma Granted Priority Review
June 05, 2018Duvelisib, a first-in-class dual inhibitor of PI3K-delta and -gamma, was evaluated in patients with relapsed/refractory CLL/SLL and in patients with refractory indolent non-Hodgkin lymphoma.
Reduced Intensity Salvage Allo-HCT Effective for Follicular Lymphoma
March 09, 2016Reduced intensity allogeneic hematopoietic cell transplantation (HCT) is an effective salvage treatment strategy in patients with follicular lymphoma.
Study Identifies Factors Influencing Advanced Follicular Lymphoma Outcomes
January 22, 2016Induction therapy with lenalidomide plus rituximab may result in control that is comparable to rituximab plus chemotherapy for the initial treatment.
Early relapse of follicular lymphoma may increase risk of death
July 02, 2015Early relapse of follicular lymphoma could be carefully considered when making decisions about treatment for these patients.
Managing follicular lymphoma
July 17, 2014Changes in how follicular lymphoma is managed have led to substantial improvement in prognosis and over all survival for patients with the disease.
New treatment regimens improving outcomes for follicular lymphoma
September 19, 2013Vaccines and monoclonal antibodies are promising new treatments for patients with follicular lymphoma.
Watchful waiting strategy OK in low-tumor burden follicular lymphoma
September 26, 2012Compared with rituximab, an initial watch-and-wait strategy is not detrimental in select patients.
Stem cell treatment does not improve overall survival in follicular lymphoma
January 12, 2012High-dose chemotherapy combined with autologous stem cell transplantation did not improve overall survival in previously untreated adult patients with follicular lymphoma.
Sign Up for Free e-newsletters
ONA Articles
- Steering Patients Toward Reliable Internet Resources
- ADT May Up Risk for Heart Failure in Prostate Cancer Patients
- PFS, OS Improved With Sequential Rituximab/Bendamustine, Rituximab/Cytarabine in Untreated Mantle Cell Lymphoma
- Patients, Physicians Do Not Recognize Fatigue the Same
- Alternative Medicine Beliefs: How Far Will Cancer Patients Go for Alternative Results?
- Counseling Patients on Oral Chemotherapy
- Smartphone App Improves Management of Cancer-Related Pain, Anxiety
- Steering Patients Toward Reliable Internet Resources
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
- Many Americans Unaware of the Promise of Personalized Medicine
- Alternative Medicine Beliefs: How Far Will Cancer Patients Go for Alternative Results?
- Steering Patients Toward Reliable Internet Resources
- Postmastectomy Breast Reconstruction Safe in Older Women With Breast Cancer
- CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |